Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,266 | -38,966 | -24,320 | -16,108 | -14,041 |
| Depreciation Amortization | 252 | 21 | 16 | 13 | 6 |
| Accounts payable and accrued liabilities | 1,700 | -352 | 91 | -488 | 584 |
| Other Working Capital | 2,431 | -724 | -3,131 | -5,439 | 857 |
| Other Operating Activity | -849 | 6,694 | 473 | 467 | -133 |
| Operating Cash Flow | $-8,732 | $-33,327 | $-26,871 | $-21,555 | $-12,727 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-10 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,146 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -2,057 | -1,216 | -811 | -405 |
| Common Stock Issued | N/A | 50,070 | 3 | N/A | N/A |
| Other Financing Activity | -230 | -4,532 | 0 | 0 | -6 |
| Financing Cash Flow | $13,916 | $43,481 | $-1,213 | $-811 | $-411 |
| Beginning Cash Position | 48,942 | 38,788 | 38,788 | 38,788 | 38,788 |
| End Cash Position | 54,116 | 48,942 | 10,704 | 16,422 | 25,650 |
| Net Cash Flow | $5,174 | $10,154 | $-28,084 | $-22,366 | $-13,138 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,732 | -33,327 | -26,871 | -21,555 | -12,727 |
| Capital Expenditure | -10 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -8,742 | -33,327 | -26,871 | -21,555 | -12,727 |